These findings indicate that RBP7 regulates adipocyte formation by increasing nuclear RA availability and suggest that its overactivity may contribute to obesity development, making it a potential target for obesity treatment [54]. The gene discussed is RBP7; the disease is obesity due to melanocortin 4 receptor deficiency.